[Serum concentration of selected neoplasm markers: CA15-3, TPS and CEA in women with diagnosed breast benign disease].
The aim of the study was the assessment of serum concentrations of selected neoplasmatic markers: CA15-3, TPS and CEA in women with established diagnosis of benign breast disease (BBD) using hormone replacement therapy (HRT) for average 3 years. 120 women with BBD were divided to 2 groups: HRT-users (n1 = 24) and HRT-non-users (n2 = 96). 31 healthy, regularly menstruating, age-matched women served as control group. Concentrations of all markers were measured with immunoradiometric methods. In all groups serum concentrations of measured markers were within normal range. We conclude that hormone replacement therapy has no influence on serum concentrations of CA15-3, TPS and CEA.
Kochańska-Dziurowicz
A
A
Zakładu Radiobiologii i Radiofarmaceutyków SAM w Sosnowcu.
Pasich
R
R
Stanjek
A
A
Gaweł-Szostek
V
V
Jankowski
T
T
D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood* / Q000175:diagnosis; D002272:Carcinoembryonic Antigen / Q000097:blood*; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008875:Middle Aged; D018396:Mucin-1 / Q000097:blood*; D019396:Tissue Polypeptide Antigen / Q000097:blood*
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D018396:Mucin-1; D019396:Tissue Polypeptide Antigen